# Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

> **NCT01456195** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 421 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Placebo
- **DRUG:** Fasiglifam

## Key facts

- **NCT ID:** NCT01456195
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 421 (ACTUAL)
- **Last updated:** 2016-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01456195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01456195, "Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01456195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*